A detailed history of Torno Capital, LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Torno Capital, LLC holds 5,000 shares of CSTL stock, worth $166,550. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,000
Holding current value
$166,550
% of portfolio
0.01%

Shares

0 transactions
Quarter Operation Price Per share shares change shares Held SEC Form

Others Institutions Holding CSTL

About CASTLE BIOSCIENCES INC


  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $876M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Torno Capital, LLC Portfolio

Follow Torno Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Torno Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Torno Capital, LLC with notifications on news.